Mutated p53 protein expression and proliferative activity in advanced gastric cancer

Hepato-Gastroenterology

Volumn 46, Issue 28, 1999, Pages 2648-2653

  Ikeguchi, Masahide ^a   Saito, Hiroaki ^a   Kondo, Akira ^a   Tsujitani, Shunichi ^a   Maeta, Michio ^a   Kaibara, Nobuaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

DNA ploidy pattern; Gastric adenocarcinoma; Ki 67 labeling index; p53 labeling index; Prognosis; Serosal invasion

Indexed keywords

CELL DNA; MONOCLONAL ANTIBODY KI 67; MUTANT PROTEIN; PROTEIN P21; PROTEIN P53;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LABELING INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEROSA; STOMACH CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032853716     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 1991; 351:453-456.
2. waf1/cip1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene 1995; 55:1899-1905.
3. Iggo R, Gatter K, Bartec J, Harris AL: Increased expression of mutant form of p53 oncogene in primary lung cancer. Lancet 1990; 335:675-679.
4. Hollstein MC, Metcalf RA, Welsh JA, Montesano R, Harris CC: Frequent mutation of p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 1990; 87:9958-9961.
5. Rodrigues NR, Rowan A, Smith MEF, Kerr IB, Bodmer WF, Gannon JV, Lane DP: p53 mutation in colorectal cancer. Proc Natl Acad Sci USA 1990; 87:7555-7559.
6. Harris CC: p53: At the crossroad of molecular carcinogenesis and risk assessment. Science 1993; 262:1980-1981.
7. Gerdes J, Li L, Schlueter C, Duchrow, M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD: Immunobiochemical and molecular biologic characterization of cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991; 138:867-873.
8. Japanese Research Society for Gastric Cancer: The General Rules for the Gastric Cancer Study. First English Edition, Tokyo: Kanehara, 1995.
9. Gomyo Y, Ikeda M, Osaki M, Tatebe S, Tsujitani S, Ikeguchi M, Kaibara N, Ito H: Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma. Cancer 1997; 79:2067-2072.
10. Ikeguchi M, Saitou H, Katano K, Tsujitani S, Maeta M, Kaibara N: Correlation between the lymphocytic infiltration of tumors and the proliferative activity of cancer cells from surgically treated esophageal carcinoma. Oncology 1997; 54:311-317.
11. cki gene in malignant gliomas. Int J Cancer 1995; 62:115-117.
12. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983; 31:1333-1335.
13. Kakeji Y, Korenaga D, Tsujitani S, Baba H, Anai H, Maehara Y, Sugimachi K: Gastric cancer with p53 overexpression has high potential for metastasizing to lymph node. Br J Cancer 1993; 67:589-593.
14. Yamaguchi A, Makimoto K, Goi T, Takeuchi K, Maehara M, Isobe Y, Nakagawa G: Overexpression of p53 protein and proliferative activity in colorectal adenoma. Oncology 1994; 51:224-227.
15. Nishioka H, Hiasa Y, Hayashi I: Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferation cell nuclear antigen staining and correlation with clinicopathological findings. Oncology 1993; 50:426-429.
16. Starzynska T, Bromley M, Ghosh A, Stern PL: Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 1992; 66:558-562.
17. Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F: p53 expression and prognosis in gastric carcinoma. Int J Cancer 1992; 50:859-862.
18. Motojima K, Furui J, Kohara N, Ito T, Kanematsu T: Expression of p53 protein in gastric carcinomas is not independently prognostic. Surg 1994; 116:890-895.
19. Gabbert HE, Muller W, Schneider A, Meier S, Hommel G: The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 1995; 76:720-726.
20. Kaibara N, Nishidoi H, Kimura O, Makino M, Sumi K, Koga S: Analysis of results of surgical treatment of gastric cancer. Retrospective study of 1,215 curatively resected cases. Dig Surg 1988; 5:124-127.
21. Machara Y, Okuyama T, Oshiro T, Baba H, Adachi Y, Sugimachi K; Analysis of 390 patients surviving 10 years or longer after curative resection for gastric cancer. Oncology 1994; 51:366-371.